# Ikarian Capital

Ikarian Capital is an Asset Manager based in Dallas, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Dallas, United States
- **Region:** North America
- **Address:** 100 Crescent Court, Suite 1620, Dallas, TX 75201, United States
- **Assets under management:** Undisclosed
- **Website:** ikariancapital.com
- **LinkedIn:** https://www.linkedin.com/company/ikarian-capital-llc

## Regulatory record

- **CRD number:** 281880
- **SEC file number:** 801-118894
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/281880

## About

Ikarian Capital is an SEC-registered investment adviser in Dallas, TX, registered since 2020. The firm manages approximately $698 million in regulatory assets. It has 8 employees and 3 investment advisers.

## Sectors

- Biotech
- Digital Health

## Offices

- San Diego
- San Francisco

## Questions

### Who leads investment decisions at Ikarian Capital?

The founding team is composed of professionals with scientific and finance backgrounds, but individual principals are not named publicly on the firm's website. The team’s combined expertise spans drug discovery and biotech-specific finance.

### How does Ikarian Capital source proprietary deal flow?

The firm claims a proprietary process that relies on its team's core expertise in biotech science and finance. It describes itself as selective and contrarian, seeking opportunities overlooked by larger investors. Specific sourcing methods or networks have not been detailed publicly.

### What investment stages does Ikarian Capital target?

Ikarian Capital invests across the entire clinical development spectrum, from early- to late-stage trials. It is agnostic to indication, market cap, and geography, allowing flexibility in stage preference based on scientific merit.

### Which sectors does Ikarian Capital explicitly avoid?

The firm is solely focused on biotech and therapeutic innovation. It does not invest in sectors outside drug discovery and development, such as real estate, energy, or consumer goods.

## Related profiles

- [Beacon Oral Specialists](https://altss.com/profile/beacon-oral-specialists)
- [Cowen Inc.](https://altss.com/profile/cowen-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ikarian-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology